Pacira Biosciences
PCRX
#5416
Rank
HK$8.16 B
Marketcap
HK$176.33
Share price
2.95%
Change (1 day)
-25.59%
Change (1 year)
Categories

Operating Margin for Pacira Biosciences (PCRX)

Operating Margin as of March 2025 (TTM): -7.08%

According to Pacira Biosciences 's latest financial reports and stock price the company's current Operating Margin is -7.08%. At the end of 2024 the company had an Operating Margin of -7.09%.

Operating Margin history for Pacira Biosciences from 2010 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-7.09%-160.53%
202311.71%59.7%
20227.33%-53.52%
202115.77%55.39%
202010.15%282.43%
20192.65%-55%
20185.90%-165.5%
2017-9.00%-20.75%
2016-11.36%-406.45%
20153.71%-224.51%
2014-2.98%-95.59%
2013-67.43%-47.78%
2012-129.14%-47.44%
2011-245.70%54.29%
2010-159.25%-16.29%
2009-190.24%-41.6%
2008-325.77%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
4.99%-170.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-79.07% 1,016.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-994.20% 13,942.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-5.23%-26.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-467.67% 6,505.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-259.55% 3,565.99%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.